(R)-3-((tert-Butoxycarbonyl)amino)-3-(2,4-dichlorophenyl)propanoic acid, 95.0%, 1g

5-Iodo-6-methyl-2-oxo-1,2-dihydro-pyridine-3-carbonitrile, 95%, 1g

Tri-potassium citrate monohydrate, min. 99%, Ph.Eur., USP, 2.5 kg, plastic packaging.

Sodium hydroxide solution 45%, extra pure, 2.5 l, plastic packaging.

4-Fluorocyclohexanone, 95.0%, 250mg

2,4-Dichloro-6,7-dihydrothieno[3,2-d]pyrimidine, 95.0%, 100g

Bis(2,4-pentanedionato)zinc(II)>96.0%(T)500g

ETHYL 4-CHLORO-2-IODOBENZOATE, 95.0%, 1g

2-(1-METHYLCYCLOPROPYL)ETHAN-1-OL, 95.0%, 10g

1,1'-(5'-(4-(1H-Imidazol-1-yl)phenyl)-[1,1':3',1''-terphenyl]-4,4''-diyl)bis(1H-imidazole), 97%, 250mg

7-Bromo-3,4-dihydro-2H-benzo[b][1,4]oxazine, 95.0%, 250mg

Methyl 2-((tert-butoxycarbonyl)amino)-2-(4-chlorophenyl)acetate, 97%, 250mg

4'-Ethynyl-[1,1'-biphenyl]-4-ol, 95.0%, 5g